Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells.

Chen Z, Nishimura N, Okamoto T, Wada K, Naora K.

Biomed Res Int. 2019 Nov 22;2019:1269532. doi: 10.1155/2019/1269532. eCollection 2019.

2.

Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.

Yamashita H, Okada A, Naora K, Hongoh M, Kinoshita Y.

Dig Dis Sci. 2019 Mar;64(3):823-831. doi: 10.1007/s10620-018-5377-9. Epub 2018 Nov 21.

3.

Effect of Timing of Proton Pump Inhibitor Administration on Acid Suppression.

Furuta K, Adachi K, Aimi M, Shimura S, Mikami H, Nishimura N, Ishimura N, Ishihara S, Naora K, Kinoshita Y.

Digestion. 2016;93(2):111-20. doi: 10.1159/000441972. Epub 2015 Dec 4.

PMID:
26637113
4.

Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen.

Ishihara N, Nishimura N, Tamaki H, Karino F, Miura K, Isobe T, Ikawa K, Morikawa N, Naora K.

Int J Clin Pharmacol Ther. 2015 Jun;53(6):422-9. doi: 10.5414/CP202191.

PMID:
25828635
5.

[Questionnaire-based study on the key to the guidance to the patients with atopic dermatitis by pharmacist].

Kaneko S, Kakamu T, Matsuo H, Naora K, Morita E.

Arerugi. 2014 Nov;63(9):1250-7. Japanese.

PMID:
25492880
6.

Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison.

Furuta K, Kohata Y, Fujiwara Y, Sugimoto M, Uotani T, Yamade M, Sahara S, Ichikawa H, Furuta T, Nio K, Iwakiri R, Inamori M, Kawamura O, Kusano M, Kato M, Kawami N, Iwakiri K, Takeuchi T, Higuchi K, Aimi M, Naora K, Fujimoto K, Arakawa T, Kinoshita Y.

J Clin Biochem Nutr. 2014 Nov;55(3):178-83. doi: 10.3164/jcbn.14-41. Epub 2014 Oct 4.

7.

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.

Tamaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H, Naora K, Harada M.

Oncotarget. 2014 Nov 30;5(22):11399-412.

8.

Effects of omeprazole on sleep disturbance: randomized multicenter double-blind placebo-controlled trial.

Aimi M, Komazawa Y, Hamamoto N, Yamane Y, Furuta K, Uchida Y, Yano S, Morita M, Oguro H, Miyake T, Sugimoto T, Nagi S, Naora K, Goubaru Y, Ishihara S, Kinoshita Y.

Clin Transl Gastroenterol. 2014 Jun 19;5:e57. doi: 10.1038/ctg.2014.8.

9.

Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux.

Morita T, Furuta K, Adachi K, Ohara S, Tanimura T, Koshino K, Uemura T, Naora K, Kinoshita Y.

J Neurogastroenterol Motil. 2012 Apr;18(2):181-6. doi: 10.5056/jnm.2012.18.2.181. Epub 2012 Apr 9.

10.

Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.

Nishimura N, Uemura T, Iwamoto K, Naora K.

J Pharm Pharmacol. 2010 May;62(5):651-7. doi: 10.1211/jpp/62.05.0014.

PMID:
20609069
11.

[Pharmaceutical analysis and clinical efficacy of Kampo medicine, maoto, extract suppository against pediatric febrile symptoms].

Nishimura N, Doi N, Uemura T, Taketani T, Hayashi G, Kasai T, Kanai R, Yamaguchi S, Iwamoto K, Naora K.

Yakugaku Zasshi. 2009 Jun;129(6):759-66. Japanese.

12.

Transepithelial permeation of tolbutamide across the human intestinal cell line, Caco-2.

Nishimura N, Naora K, Uemura T, Hirano H, Iwamoto K.

Drug Metab Pharmacokinet. 2004 Feb;19(1):48-54.

13.

Comparative study on salivary distribution of fluoroquinolones in rats.

Li Q, Naora K, Hirano H, Okunishi H, Iwamoto K.

Biol Pharm Bull. 2002 Aug;25(8):1084-9.

14.

Changes in the dissolution of tolbutamide by a traditional Chinese medicine, Sho-saiko-to (Xiao Chaihu Tang).

Nishimura N, Naora K, Hirano H, Iwamoto K.

Biol Pharm Bull. 2001 Apr;24(4):409-13.

15.
16.
17.

Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure.

Naora K, Ichikawa N, Hirano H, Iwamoto K.

J Pharm Pharmacol. 1999 May;51(5):609-16.

PMID:
10411221
18.

Quantitation of acetazolamide in rat plasma, brain tissue and cerebrospinal fluid by high-performance liquid chromatography.

Ichikawa N, Naora K, Hirano H, Iwamoto K.

J Pharm Biomed Anal. 1998 Sep;17(8):1415-21.

PMID:
9800660
19.

Excretion of ofloxacin into saliva in rats with renal failure.

Ding G, Naora K, Nagasako S, Hirano H, Iwamoto K.

J Pharmacol Exp Ther. 1998 Oct;287(1):31-6.

PMID:
9765318
20.

Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats.

Nishimura N, Naora K, Hirano H, Iwamoto K.

J Pharm Pharmacol. 1998 Feb;50(2):231-6.

PMID:
9530993
21.

Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro.

Ichikawa N, Naora K, Hirano H, Hashimoto M, Masumura S, Iwamoto K.

J Pharmacol Toxicol Methods. 1996 Sep;36(1):45-52.

PMID:
8872919
22.

Saturable transport of valproic acid in rat choroid plexus in vitro.

Naora K, Ichikawa N, Nishimura N, Hirano H, Shen DD, Iwamoto K.

J Pharm Sci. 1996 Apr;85(4):423-6.

PMID:
8901082
23.

Mechanism of valproic acid uptake by isolated rat brain microvessels.

Naora K, Shen DD.

Epilepsy Res. 1995 Oct;22(2):97-106.

PMID:
8777904
24.

Effect of fenbufen on the penetration of quinolone antibiotics into cerebrospinal fluid. Comparative study with 5 quinolones.

Iwamoto K, Ichikawa N, Naora K, Hirano H.

Drugs. 1995;49 Suppl 2:349-51. No abstract available.

PMID:
8549358
25.
26.

High-performance liquid chromatographic determination of nalidixic acid in rat serum, brain and cerebrospinal fluid.

Ichikawa N, Naora K, Hayashibara M, Iwamoto K.

J Pharm Biomed Anal. 1993 Oct;11(10):993-7.

PMID:
8305605
27.

Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats.

Ichikawa N, Naora K, Hayashibara M, Katagiri Y, Iwamoto K.

J Pharm Pharmacol. 1992 Nov;44(11):915-20.

PMID:
1361537
28.

Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats.

Naora K, Katagiri Y, Iwamoto K, Tanaka K, Yamaguchi T, Sekine Y.

J Antimicrob Chemother. 1992 Nov;30(5):673-83.

PMID:
1337351
29.

Pharmacokinetics of [6]-gingerol after intravenous administration in rats with acute renal or hepatic failure.

Naora K, Ding G, Hayashibara M, Katagiri Y, Kano Y, Iwamoto K.

Chem Pharm Bull (Tokyo). 1992 May;40(5):1295-8.

PMID:
1394650
30.

Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen.

Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K.

J Pharmacol Exp Ther. 1991 Sep;258(3):1033-7.

PMID:
1890610
31.

Pharmacokinetics of [6]-gingerol after intravenous administration in rats.

Ding GH, Naora K, Hayashibara M, Katagiri Y, Kano Y, Iwamoto K.

Chem Pharm Bull (Tokyo). 1991 Jun;39(6):1612-4.

PMID:
1934184
32.

High-performance liquid chromatographic determination of ciprofloxacin in rat brain and cerebrospinal fluid.

Katagiri Y, Naora K, Ichikawa N, Hayashibara M, Iwamoto K.

Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2884-6.

PMID:
2076578
33.

A possible reduction in the renal clearance of ciprofloxacin by fenbufen in rats.

Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K.

J Pharm Pharmacol. 1990 Oct;42(10):704-7.

PMID:
1982142
34.

Simultaneous high-performance liquid chromatographic determination of ciprofloxacin, fenbufen and felbinac in rat plasma.

Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K.

J Chromatogr. 1990 Aug 24;530(1):186-91. No abstract available.

PMID:
2277110
35.

A minor possibility of pharmacokinetic interaction between enoxacin and fenbufen in rats.

Naora K, Katagiri Y, Ichikawa N, Hayashibara M, Iwamoto K.

J Pharmacobiodyn. 1990 Feb;13(2):90-6.

PMID:
2384853
36.

High-performance liquid chromatographic procedure for the simultaneous determination of norfloxacin, fenbufen and felbinac in rat plasma.

Katagiri Y, Naora K, Ichikawa N, Hayashibara M, Iwamoto K.

Chem Pharm Bull (Tokyo). 1989 Oct;37(10):2858-60.

PMID:
2611947
37.

Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats.

Katagiri Y, Naora K, Ichikawa N, Hayashibara M, Iwamoto K.

J Pharm Pharmacol. 1989 Oct;41(10):717-9.

PMID:
2575153
38.

Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.

Katagiri Y, Mabuchi K, Itakura T, Naora K, Iwamoto K, Nozu Y, Hirai S, Ikeda N, Kawai T.

Cancer Chemother Pharmacol. 1989;23(4):238-42.

PMID:
2538250
39.

Enhanced bioavailability of morphine after rectal administration in rats.

Katagiri Y, Itakura T, Naora K, Kanba Y, Iwamoto K.

J Pharm Pharmacol. 1988 Dec;40(12):879-81.

PMID:
2907583
40.

Simultaneous determination of ofloxacin, fenbufen and felbinac in rat plasma by high-performance liquid chromatography.

Katagiri Y, Naora K, Ichikawa N, Hayashibara M, Iwamoto K.

J Chromatogr. 1988 Sep 23;431(1):135-42.

PMID:
3235524

Supplemental Content

Support Center